Iterum Therapeutics Plc (ITRM)

전일 마감가:

$1.58

열려 있는:

$1.58

하루 거래량:

46,917

시가총액:

$25.66M

수익:

-

순이익/손실:

$-31.10M

주가수익비율:

-0.3429

EPS:

-4.52

순현금흐름:

$-30.81M

1주 성능:

-7.19%

1개월 성능:

+0.00%

6개월 성능:

+106.67%

1년 성능:

+37.17%

1일 변동 폭

$1.52

$1.63

52주 변동 폭

$0.622

$2.50

Iterum Therapeutics Plc Stock (ITRM) Company Profile

명칭

Iterum Therapeutics Plc

부문

Healthcare (1213)

산업

Biotechnology (699)

전화

353 1 669 4820

주소

Fitzwilliam Court, 1st Floor Leeson Close, Dublin

직원

13

트위터

다음 수익 날짜

2024-05-10

최신 SEC 제출 서류

ITRM's Discussions on Twitter

Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2021-05-28	업그레이드	Gabelli & Co	Sell → Hold
2021-03-15	업그레이드	H.C. Wainwright	Neutral → Buy
2020-06-02	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2020-01-21	다운그레이드	Gabelli & Co	Buy → Sell
2019-12-11	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2019-06-21	개시	H.C. Wainwright	Buy

모두보기

Iterum Therapeutics Plc 주식(ITRM)의 최신 뉴스

Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem

GlobeNewswire Inc.

Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

GlobeNewswire Inc.

Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat

GlobeNewswire Inc.

Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up

Zacks Investment Research

Insiders Buying Iterum Therapeutics And 3 Other Stocks Under $3

Benzinga

Iterum Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on November 14, 2023

GlobeNewswire Inc.

Iterum Therapeutics Plc (ITRM) 재무 분석

Iterum Therapeutics Plc (ITRM) 순이익 2024

Iterum Therapeutics Plc (ITRM) 현금흐름 2024

Iterum Therapeutics Plc (ITRM) 주당 순이익 2024

Iterum Therapeutics Plc 주식 (ITRM) 내부자 거래